Modern aspects of anti-viral therapy for hepatitis D

Modern aspects of anti-viral therapy for hepatitis D

Viral hepatitis D (HDV infection) worsens the prognosis of HBV infection course in 80-90% of cases, accelerating fibrosis and leading to liver cirrhosis or hepatocellular carcinoma. Hepatitis D affects at least 125 000 people in Russia, and in the world, according to rough estimates, there are 15–20...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Zheleznova, K. A. Svirin, M. Yu. Kartashov
Format:	Article
Language:	Russian
Published:	Journal Infectology 2024-09-01
Series:	Журнал инфектологии
Subjects:	hepatitis d hepatitis d virus antiviral therapy bulevirtide lonafarnib nucleic acid polymers
Online Access:	https://journal.niidi.ru/jofin/article/view/1659
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacotherapy of hepatitis D: the current and the future
by: George Sarin Zacharia, et al.
Published: (2025-05-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Current and future therapeutic options for chronic hepatitis D virus infection
by: Mariantonietta Pisaturo, et al.
Published: (2025-02-01)

Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV
by: Maria Paola Anolli, et al.
Published: (2025-03-01)

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
by: P. O. Bogomolov, et al.
Published: (2024-12-01)

Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug–Drug Interactions
by: Martina Billi, et al.
Published: (2025-02-01)

Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study
by: Luca Rinaldi, et al.
Published: (2025-02-01)

ETIOTROPIC THERAPY OF VIRAL HEPATITIS
by: S. B. Chuelov, et al.
Published: (2017-09-01)

Modern etiotropic therapy of chronic viral hepatitis B
by: E. B. Bun'kova, et al.
Published: (2024-10-01)

Genotypic Diversity of Hepatitis C Virus in Tuberculosis Patients in the Tomsk Region
by: K. A. Svirin, et al.
Published: (2025-03-01)

Chronic Hepatitis D Virus Infection and Its Treatment: A Narrative Review
by: Poonam Mathur, et al.
Published: (2024-10-01)

National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021
by: Olena Nesterova
Published: (2025-07-01)

Hepatitis D virus: update on epidemiology and challenges in China
by: ZOU Huaibin, YAO Chengxuan, DUAN Zhongping, REN Feng, CHEN Yu
Published: (2025-02-01)

A novel in vitro system for simultaneous infections with hepatitis B, C, D and E viruses
by: Roxanne Fouillé, et al.
Published: (2025-05-01)

Editorial: Unsolved challenges in hepatitis B and hepatitis C: host-virus interaction, molecular pathogenesis and treatment strategies
by: Peng Huang, et al.
Published: (2025-03-01)

Interferon Lambda: The Next Frontier in Antiviral Therapy?
by: Sofia Chronopoulou, et al.
Published: (2025-05-01)

CRISPR-Cas for hepatitis virus: a systematic review and meta-analysis of diagnostic test accuracy studies
by: Zhenzhen Pan, et al.
Published: (2025-03-01)

Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation
by: Joaquin Cabezas, et al.
Published: (2025-05-01)

Hepatitis E virus infection among blood donors in Ningbo
by: PENG Mingxi, et al.
Published: (2025-01-01)

Development of a novel hepatitis B virus encapsidation detection assay by viral nucleocapsid-captured quantitative RT-PCR
by: Dong-Kyun Ryu, et al.
Published: (2015-11-01)

Hepatitis C Virus Resistance-Associated Substitutions in Mexico
by: Alexis Jose-Abrego, et al.
Published: (2025-01-01)

Regulation of viral hepatitis by N6-methyladenosine RNA methylation
by: Jae-Su Moon, et al.
Published: (2025-12-01)

Chronic viral hepatitis B and D in pregnant women: course and outcomes (review)
by: M. D. Akhmedova, et al.
Published: (2021-07-01)

Prospect of emerging treatments for hepatitis B virus functional cure
by: Rex Wan-Hin Hui, et al.
Published: (2025-02-01)

PREVALENCE OF MARKERS OF VIRAL HEPATITIS B AND D FROM HEALTHY POPULATION IN REPUBLIC TYVA
by: T. V. Kozhanova, et al.
Published: (2015-08-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

Hepatocellular carcinoma patients with undetectable baseline hepatitis B viral DNA may benefit from immunotherapy
by: Yan Jian, et al.
Published: (2025-07-01)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
by: Ying Lu, et al.
Published: (2021-01-01)

Effects of hepatitis B virus infection and antiviral therapy on the clinical prognosis of nasopharyngeal carcinoma
by: Jing‐Jin Weng, et al.
Published: (2020-01-01)

Viral hepatitis in children: state and prospects for solving the problem
by: L. G. Goriacheva, et al.
Published: (2021-12-01)

The incidence of chronic viral hepatitis and the analysis of the genetic diversity of hepatitis B and C viruses among the population of Khabarovsk city
by: Valeriya O. Kotova, et al.
Published: (2025-03-01)

Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China?
by: Zhitao Wang, et al.
Published: (2025-07-01)

Relationships between low serum vitamin D levels and HBV “a” determinant mutations in chronic hepatitis B patients
by: Huijuan Zhu, et al.
Published: (2016-09-01)

A prospective study to evaluate the clinical specificity of the cobas® MPX test kit for screening for HIV RNA, HCV RNA, and HBV DNA in blood donation samples using the cobas® 6800 system in HBV endemic areas
by: Lei Zhou, et al.
Published: (2025-02-01)

Momentum towards simplifying and expanding treatment for chronic hepatitis B: The body of evidence continues to grow: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
by: Robert J. Wong
Published: (2025-04-01)

The prevalence of viral hepatitis D in the world
by: V. G. Akimkin, et al.
Published: (2022-07-01)

Betaleukin in therapy of chronic hepatitis C
by: E. S. Romanova, et al.
Published: (2014-10-01)

The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
by: Suparno Chakrabarti, et al.
Published: (2009-12-01)

Vaccination Effect on Epidemic Process of Viral Hepatitis B In Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2019-03-01)